The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 08, 2024

Filed:

Feb. 16, 2023
Applicant:

Design-zyme Llc, Lawrence, KS (US);

Inventors:

Peter Albert Petillo, Lawrence, KS (US);

Dwight O'Dell Deay, III, Lawrence, KS (US);

Assignee:

DESIGN- ZYME LLC, Lawrence, KS (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q 1/00 (2006.01); C07K 1/00 (2006.01); C07K 1/107 (2006.01); C12N 9/02 (2006.01); C12N 9/04 (2006.01); C12N 9/06 (2006.01); C12P 21/00 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/005 (2013.01); C07K 1/006 (2013.01); C07K 1/1077 (2013.01); C12N 9/0004 (2013.01); C12N 9/0006 (2013.01); C12P 21/005 (2013.01);
Abstract

The present invention is broadly concerned with new in vitro glycosylation methods that provide rational approaches for producing glycosylated proteins, and the use of glycosylated proteins. In more detail, the present invention comprises methods of glycosylating a starting protein having an amino sidechain with a nucleophilic moiety, comprising the step of reacting the protein with a carbohydrate having an oxazoline moiety on the reducing end thereof, to covalently bond the amino sidechain of the starting protein with the oxazoline moiety, wherein the glycosylated protein substantially retains the structure and function of the starting protein. Target proteins include oxidase, oxidoreductase and dehydrogenase enzymes. The glycosylated proteins advantageously have molecular weights of at least about 7500 Daltons. In a further embodiment, the present invention concerns the use of glycosylated proteins, fabricated by the methods disclosed herein, in the assembly of amperometric biosensors.


Find Patent Forward Citations

Loading…